VTRS FY 2017 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

FY 2017 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$11.9B+7.5% YoY

Gross Profit

$4.8B40.2% margin

Operating Income

$1.4B12.1% margin

Net Income

$696M5.8% margin

EPS (Diluted)

$1.30

Cash Flow

Operating Cash Flow

$2.1B

Free Cash Flow

$1.8B

Stock-Based Comp.

$75M

Balance Sheet

Total Assets

$35.8B

Total Liabilities

$22.5B

Stockholders' Equity

$13.3B

Cash & Equivalents

$292M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11.9B	$11.1B	+7.5%
Gross Profit	$4.8B	$4.7B	+1.8%
Operating Income	$1.4B	$699M	+105.5%
Net Income	$696M	$480M	+45.0%